Table 1

Participant characteristics

CharacteristicDiffusion tensor imaging (study I)*Voxel-based morphometry (study II)*
Controls (n = 10)PMDD (n = 57)Controls (n = 42)PMDD (n = 89)
Age, yr30.30 ± 6.7035.14 ± 6.31§28.00 ± 6.0033.00 ± 7.00§
Body mass index, kg/m222.94 ± 3.1124.45 ± 4.3423.80 ± 3.8024.10 ± 4.00
Total intracranial volume, L1.47 ± 0.101.47 ± 0.101.52 ± 0.111.50 ± 0.10
Menstrual cycle length, d27 ± 228 ± 228 ± 228 ± 2
Psychiatric history4 (40.0)24 (42.1)7 (16.6)34 (39.1)
 Depressive disorder3 (75.0)18 (75)6 (85.7)27 (79.4)
 Anxiety disorder1 (25.0)6 (25)1 (14.3)6 (17.6)
 Eating disorder0 (0)3 (12.5)0 (0)4 (11.8)
Estradiol, pmol/L286.39 ± 210.13414.00 ± 251.37434.50 ± 47.40411.10 ± 239.80
Progesterone, nmol/L9.26 ± 15.0621.25 ± 16.06§18.70 ± 15.0021.90 ± 15.30
DRSP, total score§NA61.67 ± 18.39NA61.80 ± 18.20
  • DRSP = Daily Record of Severity of Problems; NA = not applicable; PMDD = premenstrual dysphoric disorder.

  • * Values are mean ± standard deviation or n (%). Differences between groups were assessed using the Mann–Whitney test for continuous variables and the Fisher exact test for categorical variables.

  • The percentage of participants who reported a psychiatric history is based on the full sample; participants could report more than 1 disorder. Percentages for depressive, anxiety and eating disorders is based on the number of participants who reported a psychiatric history. In study II, 2 participants in the PMDD group did not provide information about previous psychiatric disorders.

  • Hormone data were available for a subset of 9 controls and 55 individuals with PMDD in the diffusion tensor imaging study, and 39 controls and 85 individuals with PMDD in the voxel-based morphometry study.

  • § DRSP scores were available for a subset of 54 individuals with PMDD in the diffusion tensor imaging study, and 55 in the voxel-based morphometry study.

  • Significant group difference at p < 0.05.